Growth and Expansion Glaukos Corporation has recently increased its workforce by over 150 employees and secured significant funding of 53.2 million dollars, indicating a strategic focus on growth, innovation, and market penetration which presents opportunities for expanded product and service sales.

Innovative Therapies The company's active development of advanced glaucoma and retinal therapies, along with recent certifications like EU MDR for iStent infinite and launching next-generation visual testing platforms, highlight a strong pipeline of innovative products suitable for ophthalmic healthcare providers seeking cutting-edge solutions.

Strategic Collaborations Partnerships with Topcon Healthcare, RadiusXR, and other industry leaders for wearable vision testing platforms demonstrate Glaukos's commitment to technological integration, creating cross-selling opportunities with medical device and healthcare technology distributors.

Market Positioning Focused on the global ophthalmic market with a clear emphasis on advancing standards of care, Glaukos's niche in minimally invasive glaucoma surgery and retinal disorder treatments opens sales avenues with hospitals, clinics, and specialty clinics looking for innovative treatment options.

Technology Adoption Utilizing advanced tech stacks including AppNexus, Pardot, and Agiloft indicates a modern approach to marketing, sales, and customer relationship management, facilitating targeted outreach and digital engagement strategies to boost sales conversions.